MK-4074

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameMK-4074
Drug Alias NameMK-4074
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-CoA carboxylase 2 inhibitors
TargetsAcetyl-CoA carboxylase 2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A